Abstract Details

Title Aphasia As a Complication Of CD19-Targeted Chimeric Antigen Receptor Immunotherapy

Topic General Neurology

Presentation(s) (-)

Poster/Presentation
Number 006

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Sarah Kranick, MD (MultiCare Health System) PRESENTER	Dr. Kranick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Verana Health.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Avindra Nath, MD, MBBS, FAAN (National Institutes of Health)	Dr. Nath has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from ALS Association. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.